John Michael O'Brien

President & CEO of @npcnow. Tackling today’s greatest #healthpolicy challenges with data-driven evidence. Pharmacist & former senior @HHSGov advisor.

[NPC @npcnow]

Investors across a range of stages, investment sizes, and fund types frequently reported that the #IRA of 2022 is exacerbating challenges in bringing innovative new medicines to market, according to new research in @Health_Affairs at https://t.co/6WeA4ydC2R 🧵

[John Michael O'Brien @drjmob]

@IQVIA_Institute always hosts great webinars. I'm excited to participate in "Evolving Patient Access and Spending on Medicines in the U.S” this Thursday September 11 at 10:00 AM ET. Register to attend at
https://t.co/7gTE2hv7jD

[John Michael O'Brien @drjmob]

This summer marked the 1st anniversary of my dad's death from esophageal cancer. I can’t put a price on the memories made in his final months, but I know they were made possible by the medical innovation and the hope it provides. Read more via @LinkedIn: https://t.co/86P1ezUZl1

[John Michael O'Brien @drjmob]

Our Rutgers-NPC Fellows dream big, deliver impactful policy-relevant research, and drive better health policy — Do you aspire to do the same?

@npcnow will recruit soon for our next Health Policy & Communications Fellow. Apps open on October 8. More at https://t.co/rWsHS8cc4e

[NPC @npcnow]

💊 Significant racial and ethnic disparities exist in prescription drug utilization and spending in the U.S., according to a new study in #JAMAHealthForum from the @npcnow in partnership with the @UW.

Read the full analysis at https://t.co/ulFMNBpVET

[John Michael O'Brien @drjmob]

Click here to receive @npcnow's latest health policy research and subscribe to our weekly newsletter: https://t.co/hi0sAetjo9

[John Michael O'Brien @drjmob]

Honored to see our research on this important topic in the pages of @Health_Affairs Forefront.

https://t.co/BgxdrMB88G

[John Michael O'Brien @drjmob]

Click here to receive @npcnow's latest health policy research and subscribe to our weekly newsletter: https://t.co/hi0sAetjo9

[John Michael O'Brien @drjmob]

Cell & gene therapies (#CGTs) can be life-changing for patients — but too many barriers & obstacles impact their journey through diagnosis, treatment, & recovery. Understanding these barriers is essential to overcoming them.

Learn more in our new report: https://t.co/OJgq93INZd

[John Michael O'Brien @drjmob]

Join me at the #NatAllForum on 11/19! @sarahkemond of @icer_review, @sgremminger of @ntlalliancehlth, @CF_Pearson of @PetersonCHealth, @nilaydshah1 of @Delta, & I will discuss "Unlocking Value: Building Trusted Tools to Assess High-Value Care."

https://t.co/8mozlgrdiU

[John Michael O'Brien @drjmob]

During my residency, @AllHealthPolicy opened my eyes to the importance of good evidence — so I’m excited to participate in their Post-Election Symposium today! Join me, @AdamColborn @amcporg, @raenuzum @commonwealthfnd, & Dr. Marc Samuels @ADVIhealth: https://t.co/BC8uncdZgo

[John Michael O'Brien @drjmob]

Honored to discuss #healthpolicy, #policyanalysis, & the amazing opportunities a PharmD creates w/ students @RutgersU Ernest Mario School of Pharmacy. We discussed the unintended consequences of the #IRA's #DPNP & #PBM reform — illustrated by current events & @npcnow's research.

[John Michael O'Brien @drjmob]

Just @Allegiant instead of @AmericanAir from SRQ for the first time and wow, what a great decision. Plenty of space in their Extra seats, friendly crew, back in DC two hours before AA departs (IF on time), and I don’t have to deal with AA’s disinterested & unhappy gate agents.

[John Michael O'Brien @drjmob]

I recently joined @gregwdaniel @EliLillyandCo, @ihdezdelso @UCSanDiego, & Dr. Sean Sullivan @UW_Pharmacy for an @ISPORorg webinar on the #IRA — Medicare’s #MFPs for the first 10 negotiated drugs & anticipated cost savings.

View the recording here: https://t.co/aGMNbnMopw

[John Michael O'Brien @drjmob]

This week, @JacquelynMMcrae & I gave a fireside chat at my alma mater, @nsucopsspr, to speak w/ students in @NSUSNPhA, the Legislative Task Force, & @kpsi. We loved sharing our personal experiences & advice for working & taking action in #healthpolicy. Go Sharks!

[John Michael O'Brien @drjmob]

@dblkgolf Thinking of you all! Stay safe!

[John Michael O'Brien @drjmob]

I'm looking forward to speaking at the #FierceBiotechSummit next week in Boston! Will you be there? Let me know — I'd love to connect!

[John Michael O'Brien @drjmob]

Happy #LaborDay2024! As we celebrate workers today, I'm thrilled to share that @npcnow has been recognized as a Certified @GPTW_US. Thank you @Kim_Westrich for leading our efforts to create a culture that actively supports growth & drives excellence. https://t.co/nnm0wITjTn

[John Michael O'Brien @drjmob]

Our 2-year fellowship offers a world-class training experience for the next generation of pharmaceutical policy researchers & communicators. Learn more from current @RutgersU @npcnow Fellows at our networking session on 9/25 at 5:30PM ET!
Register here: https://t.co/2eoffY5g19

[NPC @npcnow]

We're looking for our 2025-2027 @RutgersU - NPC Health Policy & Communications Fellow! Be part of a best-in-class #healthpolicy #research organization & forge relationships w/ pharmaceutical industry leaders. Learn more below.

[NPC @npcnow]

Check out this week's @cap_rx podcast ft. @drjmob and Dr. Julie Patterson! They're discussing their recent research on how prescription rebate guarantees & #PBMs are impacting employers & patients.